View drug registration information details.
Items | Registration information |
ID | 464 |
No | 464 |
Brand Name | MONVEX-L |
Ingredients | Levocetirizine Dihydrochloride USP 5 mg, Montelukast Sodium Eq. to. Montelukast
BP 10 mg |
Dosage Form | Film coated Tablets |
Primary Packaging | Alu-Alu Blister |
Storage | Store below 30°C. Protect from light. |
Shelf Life | 3 YEARS |
Pack Size | BOX OF 3 X 10'S |
Dispensing Category | PRESCRIPTION |
ATC Classification | |
Pharmaceutical Class | ANTIHISTAMINES & ANTIALLERGICS |
Indications | for the relief of symptoms associated with seasonal and perennial allergic rhinitis. |
Contraindications | Montelukast plus Levocetirizine is contraindicated in patients with
known hypersensitivity to Montelukast or Levocetirizine, patients with
severe (creatinine clearance less than 10 ml/min) or hepatic impairment,
in children 6- 11 years of age with renal impairment, and women who
are pregnant or breastfeeding. |
Side Effects | Nausea, Skin rash, Diarrhoea, Vomiting, Dry mouth, Headache, Skin
rash, Fatigue (Weakness), Fever, Abdominal pain, Dyspepsia, Dizziness,
Congestion. |
Unit Price | |
EDL |
No |
Description | A yellow colored, round shaped, biconvex, film Coated tablet, plain on
both side. |
Note | |
License Owner | VE PRODUCTS (LAO) CO.,LTD |
Manufacturer | 4Care Lifescience Pvt. Ltd. |
Country | INDIA |
Import Registration No | G/25/2400 |
Import Registration Date | 19-03-2024 |
Activity | CERTIFICATE RELEASED |
Applied Date | 2024-10-15 |
FDD Registration No | 12 I 5835/24 |
FDD Registration Date | 2024-12-30 |
Expiry Date | 2029-12-29 |
Back to drug list
|